Agios Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $1.44B
Liabilities Breakdown FY2021
Total Liabilities: $145.8M
Asset Breakdown
Total Assets: $1.44B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $203.1M | 14.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $28.9M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.21B | 83.9% |
Liabilities Breakdown
Total Liabilities: $145.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $16.7M | 11.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $129.1M | 88.5% |